Lupin is committed to producing high quality
life-improving medicines whilst providing significant value to the NHS.
Healthcare
Professionals
Lupin Neuroscience is a specialty pharma division of Lupin. We are committed to improving the lives of patients affected by neurological disorders. Our mission is to expand patient access to science-based therapies and solutions through building a global portfolio of speciality pharmaceuticals for development, registration and commercialisation with partners and collaborators.

Lupin Healthcare has strong Respiratory R&D expertise with products filed to deliver a future broad respiratory portfolio.
GENERIC PRODUCTS | Link to EMC Website to access SMPC and PIL | FURTHER INFORMATION |
---|---|---|
Abacavir/Lamivudine (Lamivudine, abacavir hydrochloride) | HIV Medicine Portfolio | |
Desogestrel (Desogestrel) | Womens Health Portfolio | |
Emtricitabine/Tenofovir Disoproxil (Emtricitabine, tenofovir disoproxil phosphate) | HIV Medicine Portfolio | |
Feanolla (Desogestrel) | Womens Health Portfolio | |
Lansoprazole (Lansoprazole) | ||
Levetiracetam (Levetiracetam) | ||
Levonorgestrel (POM) (Levonorgestrel) | Womens Health Portfolio | |
Levonorgestrel (P) (Levonorgestrel) | Womens Health Portfolio | |
Maexeni (Ethinylestradiol, levonorgestrel) | Womens Health Portfolio | |
Memantine Hydrochloride (Memantine hydrochloride) | ||
Ropilynz (Ropinirole hydrochloride) | ||
Sertraline (Sertraline hydrochloride) | ||
Simvador (Simvastatin) | ||
Syonell ▼ (Valproate Semisodium) | Mental Health Portfolio | |
Tenofovir (Tenofovir disoproxil phosphate) | HIV Medicine Portfolio | |
Yiznell (Ethinylestradiol, drospirenone) | Womens Health Portfolio | |
Ziclaseg (Gliclazide) |
NEUROSCIENCE PRODUCTS | Link to EMC Website to access SmPC or PIL | FURTHER INFORMATION |
---|---|---|
Namuscla (Mexiletine hydrochloride) | Neuroscience Portfolio |
Reporting of side effects
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/.
By reporting side effects you can help provide more information on the safety of this medicine.
Contact Us
If you would like to get in touch, please contact us by the following:
Email to: information@lupin.com or customer services on 01565 751378
LUP-CORP-005s DOP: October 2020
Privacy Overview
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
